ScoreWhy is Sichuan Huiyu Pharmaceutical Co., Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of -15.85% and Operating profit at -139.44% over the last 5 years
2
Negative results in Sep 25
- NET SALES(HY) At CNY 502.7 MM has Grown at -17.49%
- NET PROFIT(HY) At CNY 53.87 MM has Grown at -31.32%
- ROCE(HY) Lowest at 1.24%
3
Underperformed the market in the last 1 year
- The stock has generated a return of 6.63% in the last 1 year, much lower than market (China Shanghai Composite) returns of 22.49%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Sichuan Huiyu Pharmaceutical Co., Ltd. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Sichuan Huiyu Pharmaceutical Co., Ltd.
6.65%
0.64
57.50%
China Shanghai Composite
17.07%
1.58
14.20%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-15.85%
EBIT Growth (5y)
-139.44%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.59
Sales to Capital Employed (avg)
0.24
Tax Ratio
8.98%
Dividend Payout Ratio
60.08%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
14.75%
ROE (avg)
5.57%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
99
Industry P/E
Price to Book Value
2.55
EV to EBIT
7378.72
EV to EBITDA
80.84
EV to Capital Employed
4.52
EV to Sales
7.33
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
0.05%
ROE (Latest)
2.57%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
Bearish
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend4What is working for the Company
RAW MATERIAL COST(Y)
Fallen by -5.67% (YoY
PRE-TAX PROFIT(Q)
At CNY 43.39 MM has Grown at 109.54%
NET PROFIT(Q)
At CNY 44.49 MM has Grown at 70.45%
-9What is not working for the Company
NET SALES(HY)
At CNY 502.7 MM has Grown at -17.49%
NET PROFIT(HY)
At CNY 53.87 MM has Grown at -31.32%
ROCE(HY)
Lowest at 1.24%
Here's what is working for Sichuan Huiyu Pharmaceutical Co., Ltd.
Pre-Tax Profit
At CNY 43.39 MM has Grown at 109.54%
over average net sales of the previous four periods of CNY 20.71 MMMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (CNY MM)
Net Profit
At CNY 44.49 MM has Grown at 70.45%
over average net sales of the previous four periods of CNY 26.1 MMMOJO Watch
Near term Net Profit trend is positive
Net Profit (CNY MM)
Raw Material Cost
Fallen by -5.67% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Sichuan Huiyu Pharmaceutical Co., Ltd.
Net Sales
At CNY 502.7 MM has Grown at -17.49%
Year on Year (YoY)MOJO Watch
Near term sales trend is very negative
Net Sales (CNY MM)
Non Operating Income
Highest at CNY 0.52 MM
in the last five periodsMOJO Watch
Increased income from non business activities may not be sustainable
Non Operating income
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
